糖尿病護理設備和藥物市場規模、佔有率及成長分析（按類型、分銷管道、最終用途和地區）－2025-2032 年產業預測

2023 年糖尿病護理設備和藥物市場規模價值 301.8 億美元，預計將從 2024 年的 325.6 億美元成長到 2032 年的 598.3 億美元，預測期內（2025-2032 年）的複合年成長率為 7.9%。

透過調節胰島素來控制血糖值對於糖尿病患者來說至關重要。根據國際糖尿病聯盟的數據，糖尿病是一個迅速成長的全球健康問題，影響著約 5.37 億成年人。糖尿病，尤其是第 2 型糖尿病的盛行率不斷上升，主要是由於肥胖率上升、不健康飲食和久坐的生活方式，尤其是在中低收入國家。患者數量的增加極大地推動了對糖尿病護理設備的需求，包括簡化血糖值管理的連續血糖監測儀。由於醫療成本上升，尤其是第 2 型糖尿病診斷數量的增加，預計市場將會成長。市場區隔正在增加對技術創新的投資，以增強胰島素輸送裝置，旨在在這個重要的醫療保健領域佔據更大的市場佔有率。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

糖尿病護理設備和藥物市場規模（按類型和複合年成長率）（2025-2032）

• 市場概覽
• BGM設備
  • 自我監測設備
  • 血糖值儀
  • 測試條
  • 《採血針》
  • 連續血糖監測裝置
  • 感應器
  • 發送器
  • 接收器
• 胰島素給藥裝置
  • 泵浦
  • 筆
  • 注射器和針頭
  • 噴射注射器

糖尿病護理設備和藥物市場規模（按分銷管道和複合年成長率）（2025-2032）

• 市場概覽
• 醫院藥房
• 零售藥局
• 糖尿病診所/中心
• 網路藥局
• 其他

糖尿病護理設備和藥物市場規模（按最終用途和複合年成長率） (2025-2032)

• 市場概覽
• 醫院
• 診斷中心
• 居家照護

糖尿病照護設備及藥物市場規模（按地區及複合年成長率）（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Novo Nordisk（Denmark）
• Medtronic（Ireland）
• Abbott Laboratories（United States）
• Johnson & Johnson（United States）
• Biocon（India）
• Eli Lilly and Company（United States）
• Roche（Switzerland）
• Bayer（Germany）
• Dexcom（United States）
• Insulet Corporation（United States）
• Tandem Diabetes Care（United States）
• Ascensia Diabetes Care（Switzerland）
• Terumo Corporation（Japan）
• Becton, Dickinson and Company（United States）
• AstraZeneca（United Kingdom）
• Pfizer（United States）
• Merck & Co.（United States）
• GlaxoSmithKline（United Kingdom）
• McKesson Corporation（United States）

結論和建議

Diabetes Care Devices and Drugs Market size was valued at USD 30.18 billion in 2023 and is poised to grow from USD 32.56 billion in 2024 to USD 59.83 billion by 2032, growing at a CAGR of 7.9% during the forecast period (2025-2032).

The management of blood glucose levels through insulin regulation is critical for individuals with diabetes, a rapidly rising global health concern affecting approximately 537 million adults according to the International Diabetes Federation. The increasing prevalence of diabetes, particularly type 2, largely stems from rising obesity rates, unhealthy diets, and sedentary lifestyles, especially in low- and middle-income countries. This growing patient population significantly drives the demand for diabetes care devices, including continuous glucose monitors, which simplify glucose management. The market is poised for growth as healthcare costs escalate alongside the rising number of diagnoses, particularly for type 2 diabetes. Manufacturers are increasingly investing in technological innovations to enhance insulin delivery devices, aiming to capture larger market shares in this vital healthcare segment.

Top-down and bottom-up approaches were used to estimate and validate the size of the Diabetes Care Devices And Drugs market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Diabetes Care Devices And Drugs Market Segments Analysis

Global Diabetes Care Devices and Drugs Market is segmented by Type, Distribution Channel, End-use and region. Based on Type, the market is segmented into BGM Devices and Insulin Delivery Devices. Based on Distribution Channel, the market is segmented into Hospital pharmacies, Retail Pharmacies, Diabetes Clinics/Centers, Online Pharmacies and Others. Based on End-use, the market is segmented into Hospitals, Diagnostic Centers and Homecare. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Diabetes Care Devices And Drugs Market

One of the primary catalysts for the expansion of the global diabetes care devices and drugs market is the continuous introduction of innovative products aimed at diabetes monitoring and treatment. A notable example is the research conducted by the Universidade de Lisboa in Portugal, which demonstrated in April 2020 that coating insulin-loaded nanoparticles with chitosan could significantly improve the oral delivery of insulin. Furthermore, the rising investments in research and development, along with collaborative efforts in the field, are expected to provide additional opportunities for market growth, reinforcing the overall advancement of diabetes management solutions.

Restraints in the Diabetes Care Devices And Drugs Market

The growth of the global diabetes care devices and drugs market may be hindered by several factors, including limited reimbursement options, stringent regulations, and increasing obesity rates in certain regions. Additionally, the lack of awareness surrounding diabetes diagnosis and treatment, particularly in emerging markets, poses a significant challenge to market expansion. These obstacles can lead to reduced accessibility and adoption of diabetes care solutions, further impeding the development of the market. Addressing these issues will be essential to enhance growth prospects and improve the overall effectiveness of diabetes management strategies worldwide.

Market Trends of the Diabetes Care Devices And Drugs Market

The Diabetes Care Devices and Drugs market has experienced a notable positive trend, catalyzed by the COVID-19 pandemic, which heightened awareness and concern over diabetes management among patients. With diabetics facing elevated risks from the virus, the demand for advanced monitoring devices surged as individuals sought to manage their condition more effectively from home. This shift resulted in a significant increase in the adoption of home-based diabetes care solutions, driven by a desire to minimize hospital visits. As a result, the market has seen innovations in drug formulations and device technology aimed at improving blood glucose monitoring and overall diabetes management, indicating a sustained growth trajectory in response to evolving patient needs.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Diabetes Care Devices and Drugs Market Size by Type & CAGR (2025-2032)

• Market Overview
• BGM Devices
  • Self-Monitoring Devices
  • Blood Glucose Meters
  • Testing Strips
  • Lancets
  • Continuous Glucose Monitoring Devices
  • Sensors
  • Transmitters
  • Receiver
• Insulin Delivery Devices
  • Pumps
  • Pens
  • Syringes and Needles
  • Jet Injectors

Global Diabetes Care Devices and Drugs Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospital pharmacies
• Retail Pharmacies
• Diabetes Clinics/Centers
• Online Pharmacies
• Others

Global Diabetes Care Devices and Drugs Market Size by End-use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Diagnostic Centers
• Homecare

Global Diabetes Care Devices and Drugs Market Size & CAGR (2025-2032)

• North America (Type, Distribution Channel, End-use)
  • US
  • Canada
• Europe (Type, Distribution Channel, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Distribution Channel, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Distribution Channel, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Distribution Channel, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Novo Nordisk (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocon (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dexcom (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insulet Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tandem Diabetes Care (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ascensia Diabetes Care (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• McKesson Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations